-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Analysts Set InMode Ltd. (NASDAQ:INMD) PT at $46.17
Analysts Set InMode Ltd. (NASDAQ:INMD) PT at $46.17
InMode Ltd. (NASDAQ:INMD – Get Rating) has been given a consensus rating of "Buy" by the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have covered the stock in the last year is $46.17.
INMD has been the subject of several research reports. TheStreet downgraded shares of InMode from a "b-" rating to a "c+" rating in a research report on Tuesday, September 20th. Barclays started coverage on shares of InMode in a report on Wednesday, December 21st. They set an "overweight" rating and a $44.00 target price on the stock. Finally, Jefferies Financial Group started coverage on shares of InMode in a report on Wednesday, October 12th. They set a "buy" rating and a $40.00 target price on the stock.
Get InMode alerts:InMode Trading Up 7.9 %
INMD stock opened at $35.28 on Friday. The stock has a 50-day moving average price of $35.87 and a two-hundred day moving average price of $33.10. The stock has a market cap of $2.94 billion, a PE ratio of 17.04 and a beta of 2.19. InMode has a 1 year low of $20.60 and a 1 year high of $54.68.
InMode (NASDAQ:INMD – Get Rating) last issued its earnings results on Thursday, October 27th. The healthcare company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.63 by ($0.05). InMode had a net margin of 40.93% and a return on equity of 39.52%. The firm had revenue of $121.23 million during the quarter, compared to analyst estimates of $120.70 million. On average, analysts forecast that InMode will post 2.17 earnings per share for the current fiscal year.Hedge Funds Weigh In On InMode
A number of hedge funds have recently modified their holdings of the business. JPMorgan Chase & Co. grew its holdings in InMode by 122.3% during the 1st quarter. JPMorgan Chase & Co. now owns 79,333 shares of the healthcare company's stock worth $2,928,000 after acquiring an additional 43,646 shares during the period. Bank of New York Mellon Corp increased its position in InMode by 3.9% in the 1st quarter. Bank of New York Mellon Corp now owns 110,994 shares of the healthcare company's stock valued at $4,095,000 after buying an additional 4,217 shares in the last quarter. PNC Financial Services Group Inc. increased its position in InMode by 22.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 13,087 shares of the healthcare company's stock valued at $484,000 after buying an additional 2,416 shares in the last quarter. Natixis Advisors L.P. increased its position in shares of InMode by 6.1% during the first quarter. Natixis Advisors L.P. now owns 18,591 shares of the healthcare company's stock worth $686,000 after acquiring an additional 1,076 shares in the last quarter. Finally, Panagora Asset Management Inc. bought a new stake in shares of InMode during the first quarter worth about $925,000. Institutional investors and hedge funds own 55.24% of the company's stock.
InMode Company Profile
(Get Rating)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
Further Reading
- Get a free copy of the StockNews.com research report on InMode (INMD)
- Cathie Wood Is Buying These Stocks, Should You?
- Thor Industries Hammered Its Numbers. Is it a Buy?
- Tritium Is the Largest DC EV Charger Maker You've Never Heard Of
- United Airlines Soars Ahead of Earnings...Time to Deplane?
- Is Dividend King PPG Industries A Buy Before Earnings?
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
InMode Ltd. (NASDAQ:INMD – Get Rating) has been given a consensus rating of "Buy" by the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have covered the stock in the last year is $46.17.
InMode 有限公司(NASDAQ:INMD — 獲取評級)已經被七家經紀公司提供了「買入」的共識評級,這些經紀公司目前涵蓋了股票,MarketBeat 評級報告。五位分析師對股票進行了買入評級。去年涵蓋該股票的經紀人中,平均 1 年目標價為 46.17 美元。
INMD has been the subject of several research reports. TheStreet downgraded shares of InMode from a "b-" rating to a "c+" rating in a research report on Tuesday, September 20th. Barclays started coverage on shares of InMode in a report on Wednesday, December 21st. They set an "overweight" rating and a $44.00 target price on the stock. Finally, Jefferies Financial Group started coverage on shares of InMode in a report on Wednesday, October 12th. They set a "buy" rating and a $40.00 target price on the stock.
INMD 一直是幾個研究報告的主題。在 9 月 20 日(星期二)的研究報告中,街道將 InMode 的股票從「b-」評級降級為「c +」評級。巴克萊在 12 月 21 日星期三的一份報告中開始對 InMode 的股份進行報導。他們設定了「超重」評級和 44.00 美元的股票目標價格。最後,富瑞金融集團在 10 月 12 日(星期三)的一份報告中開始覆蓋 InMode 的股份。他們設定了「買入」評級和 40.00 美元的股票目標價格。
InMode Trading Up 7.9 %
交易模式上升 7.9%
INMD stock opened at $35.28 on Friday. The stock has a 50-day moving average price of $35.87 and a two-hundred day moving average price of $33.10. The stock has a market cap of $2.94 billion, a PE ratio of 17.04 and a beta of 2.19. InMode has a 1 year low of $20.60 and a 1 year high of $54.68.
印地股票上週五以 35.28 美元開盤。該股票的 50 天移動平均價為 35.87 美元,兩百日移動平均價為 33.10 美元。該股的市值為 29.4 億美元,私募股票的私募比率為 17.04,測試版為 2.19。InMode 有一年的低點 20.60 美元和 1 年的最高點 54.68 美元。
Hedge Funds Weigh In On InMode
對沖基金權衡 InMode
A number of hedge funds have recently modified their holdings of the business. JPMorgan Chase & Co. grew its holdings in InMode by 122.3% during the 1st quarter. JPMorgan Chase & Co. now owns 79,333 shares of the healthcare company's stock worth $2,928,000 after acquiring an additional 43,646 shares during the period. Bank of New York Mellon Corp increased its position in InMode by 3.9% in the 1st quarter. Bank of New York Mellon Corp now owns 110,994 shares of the healthcare company's stock valued at $4,095,000 after buying an additional 4,217 shares in the last quarter. PNC Financial Services Group Inc. increased its position in InMode by 22.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 13,087 shares of the healthcare company's stock valued at $484,000 after buying an additional 2,416 shares in the last quarter. Natixis Advisors L.P. increased its position in shares of InMode by 6.1% during the first quarter. Natixis Advisors L.P. now owns 18,591 shares of the healthcare company's stock worth $686,000 after acquiring an additional 1,076 shares in the last quarter. Finally, Panagora Asset Management Inc. bought a new stake in shares of InMode during the first quarter worth about $925,000. Institutional investors and hedge funds own 55.24% of the company's stock.
一些對沖基金最近修改了他們對業務的持有情況。摩根大通公司於第一季度在 InMode 的持有量增長 122.3%。摩根大通公司現在擁有該醫療保健公司股票的 79,333 股,價值 2,928,000 美元,在期內另外購入 43,646 股股份後。紐約梅隆銀行在第一季度增加了 3.9% 在 InMode 的地位。紐約梅隆銀行現在擁有該醫療保健公司的 110,994 股股份,價值為 4,095,000 美元,在上一季度額外購買了 4,217 股股份。PNC 金融服務集團股份有限公司在第一季度增加了 22.6% 在 InMode 的地位。PNC 金融服務集團股份有限公司現在擁有該醫療保健公司股票的 13,087 股,價值為 484,000 美元,在上一季度額外購買 2,416 股股票後。法盛顧問第一季度增加了其在 InMode 股份的地位 6.1%。法盛顧問在上一季度額外收購 1,076 股後,現在擁有該醫療保健公司股票的 18,591 股,價值 686,000 美元。最後,Panagora 資產管理公司在第一季度購買了 InMode 股份的新股份,價值約為 925,000 美元。機構投資者和對沖基金擁有該公司股票的 55.24%。
InMode Company Profile
銀信公司簡介
(Get Rating)
(取得評分)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
InMode Ltd. 基於其在美國和國際上專有的射頻輔助脂肪分解和深層皮下分數射頻技術,設計、開發、製造和銷售微創美容醫療產品。該公司為各種程序提供微創美容醫療產品,例如吸脂和同時緊緻皮膚,身體和臉部輪廓,以及減輕皮膚嫩膚療法,以及用於女性健康狀況和程序。
Further Reading
進一步閱讀
- Get a free copy of the StockNews.com research report on InMode (INMD)
- Cathie Wood Is Buying These Stocks, Should You?
- Thor Industries Hammered Its Numbers. Is it a Buy?
- Tritium Is the Largest DC EV Charger Maker You've Never Heard Of
- United Airlines Soars Ahead of Earnings...Time to Deplane?
- Is Dividend King PPG Industries A Buy Before Earnings?
- 免費獲取有關創新科技(INMD)的研究報告
- 凱西·伍德正在購買這些股票,你應該嗎?
- 雷神工業錘擊了它的數字。它是買嗎?
- 氚是您從未聽說過的最大直流電動車充電器製造商
- 美國聯合航空公司在收入前飆升... 時間去飛機?
- 股息王 PPG 行業是否在盈利前買入?
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
接收 InMode 每日最新消息和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 InMode 和相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧